ZOE.DE Zoetis Inc. R
Healthcare · Drug Manufacturers - Specialty & Generic
61.86
-0.74%
À propos de l'entreprise
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally. The company commercializes products primarily across companion animals comprising dogs, cats, and horses; and species, including livestock, such as cattle, swine, poultry, fish, and sheep. It also offers parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaborated with Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was incorporated in 2012 and is headquartered in Parsippany, New Jersey.
Plage 52 semaines
Analyse approfondie du dividende
Zoetis Inc., a Drug Manufacturer in the Healthcare sector, offers a current dividend yield of 2.94% (EUR). Based on dividend yield theory, the stock currently appears undervalued, with its current yield well above its 5-year high of 1.36% and its 5-year average of 0.87%. The momentum score, value score, and overall rating score are not provided in the data.
Historique des dividendes
Zoetis Inc. has a dividend increase streak of 5 years, classifying it as a "Challenger" in the CCC framework. The company's dividend has grown with a 3-year compound annual growth rate (CAGR) of 15.44% and a 5-year CAGR of 20.11%. The annual dividends per share in EUR have been: 0.705 in 2020, 0.8812 in 2021, 1.1456 in 2022, 1.3218 in 2023, 1.5227 in 2024, and 1.7624 in 2025. The Chowder Number for the company is 23.1, which passes the threshold of 12.0.
Sécurité du dividende
The dividend payout ratio for Zoetis Inc. is 33.77% of earnings. The company's leverage is reflected in a debt-to-equity ratio of 293.996%. Liquidity is supported by a current ratio of 3.084 and a quick ratio of 1.575.
Quantic · Gratuit
Lis la suite de la sécurité du dividende
Avec les risques clés et ce qu'il faut surveiller ensuite. Gratuit, sans carte.
Généré par IA à partir des données de dividendes de Quantic · Mis à jour le 30 Sept 2026 · À titre informatif uniquement — pas un conseil financier.
Affiché en anglais — une traduction arrive.
Historique des prix
Profil de dividende
Fourchette de rendement Le rendement du dividende actuel d'une action comparé à sa propre fourchette des cinq dernières années — le bas, la moyenne et le haut. Près du haut, l'action paraît relativement bon marché pour le revenu qu'elle verse ; près du bas, relativement chère. C'est l'image derrière la Théorie du Rendement du Dividende. En savoir plus → (5 ans)
Calendrier des versements
Historique des dividendes
Dividende par action par année
Dette et levier
Derniers chiffres du bilan publiés.
Détenue par 1 investisseur · Suivie par 1 investisseur
Figure dans ces listes
ZOE.DE remplit les critères de ces classements de dividendes.
Nouveau dans l'investissement en dividendes ?
À titre informatif uniquement — pas un conseil financier.
Quantic · Gratuit
Suivez ZOE.DE et tout votre portefeuille
Rendement réel, sécurité du dividende, revenu net d'impôt et votre chemin vers la liberté — gratuit, sans connexion au courtier.
Besoin de plus ? Pro ajoute des portefeuilles, le suivi des revenus d'options et plus d'IA. Voir Pro →